China’s Ascentage Pharma targets $1.8b valuation in US IPO 2025-01-22T05:06:22-05:00January 22nd, 2025| share this article![#item_full_content] Read More share this article! Related Posts Japan’s teamLab art collective extends high-tech Tokyo gallery January 22nd, 2025 China’s most popular AI app gets facelift with ByteDance’s Doubao 1.5 January 22nd, 2025 ANA offers free domestic flights for passengers connecting from China January 22nd, 2025 Chinese silicon carbide device maker Inventchip bags over $137m in Series C round January 22nd, 2025
